U.S. flag

An official website of the United States government, Department of Justice.

Identification of MDMB-FUBINACA in Commercially Available E-liquid Formulations Sold for Use in Electronic Cigarettes

NCJ Number
252371
Date Published
February 2017
Length
6 pages
Author(s)
Michelle R. Peace, Rose I. Krakowiak, Carl E. Wolf, Alphonse Poklis, Justin L. Poklis
Agencies
NIJ-Sponsored
Annotation
This article reports on a project that identified designer drug MDMB-FUBINACA - chemical name methyl (S)-2-(1-(4-fluorobenzyl)-1H-indazoli-3-carboxamido)-3,3-dimethlylbutanoate – in three commercially available e-liquids formulated for electronic cigarette use.
Abstract
The e-liquids were evaluated using direct analysis in real time ion source attached to a time of flight mass spectrometer (DART-MS) and gas chromatograph mass spectrometer (GC–MS) to identify active ingredients/drugs, flavorants, and other possible constituents. The e-liquids were also evaluated for alcohol content by headspace gas chromatography with flame ionization detector (HS-GC–FID). The aerosol produced from the e-liquids by use of an e-cigarette was analyzed by solid phase micro-extraction gas chromatography mass spectrometry (SPME–GC–MS) to ensure delivery of the active ingredient/drug. Propylene glycol, vegetable glycerin, MDMB-FUBINACA, alcohol content and a flavor profile were determined for each of the e-liquids. MDMB-FUBINACA was determined to be the major active ingredient in all three e-liquids and was successfully detected by SPME–GC–MS in the aerosol generated by a KangerTech Aerotank clearomizer/electronic cigarette. 1 graphical abstract (Publisher abstract modified)
Date Created: April 30, 2019